financetom
Business
financetom
/
Business
/
Iovance Biotherapeutics Names Corleen Roche as Chief Financial Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Iovance Biotherapeutics Names Corleen Roche as Chief Financial Officer
Jul 15, 2025 5:19 AM

07:49 AM EDT, 07/15/2025 (MT Newswires) -- Iovance Biotherapeutics ( IOVA ) said Tuesday it has appointed Corleen Roche as chief financial officer, effective Aug. 6.

Roche most recently served as CFO of CG Oncology (CGON).

Iovance shares were down 6% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved